Toxigence of anthrax vaccine strains

Authors

  • G. A. Zaviriyha State Center of Innovatione Biotechnologies ,
  • U. N. Yanenko State Center of Innovatione Biotechnologies
  • N. I. Kosyanchuk National University of Life and Environmental Sciences of Ukraine,

DOI:

https://doi.org/10.31548/ujvs2020.03.009

Abstract

Abstract.  The article presents the results of the study of strains of anthrax and anthrax bacilli on the formation of toxins. We found that anthrax vaccine strains actively produce exotoxins to the culture fluid. The amount of specific protein is different under the same incubation conditions and depends on the individual characteristics of the population of microorganisms, because of this, different titers of the toxin are registered.

Strain B. anthracis K-79 Z (vaccine) with the same number of planting microbial cells and growing on the same nutrient medium and temperature produces two orders of magnitude more exotoxin than strains of B. anthracis Tsenkovsky II IVM 92 Z (virulent), B. anthracis Stern 34F2, (vaccine), B. anthracis 55 (vaccine), B. anthracis SB (vaccine), B. anthracis Tsenkovsky I (vaccine, аpathogenic). The amount of exotoxin may change as the pH of the medium changes. The activity of exotoxin production when the pH changes depends on the characteristics of the anthrax strain.
Key words: anthrax, exotoxin, exotoxin production

References

Chugh, T. (2019). Bioterrorism: Clinical and public health aspects of anthrax Current. Medicine Research and Practice. 9 (3): 110-111. https://doi.org/10.1016/j.cmrp.2019.05.004.

Shadomy, S., El Idrissi, A., & Raizman E., et al. (2016). Anthrax outbreaks: a warning for improved prevention, control and heightened awareness. Empres watch. 37(8). http://www.fao.org/3/a-i6124e.pdf.

Cizauskas, C.А., Bellan, S.E., & Turner, W.C., et al. (2014). Frequent and seasonally variable sublethal anthrax infections are accompanied by short-lived immunity in an endemic system. J Anim Ecol. 83(5): 1078-1090. http:// doi: 10.1111/1365-2656.12207.

Hendricks, K.A., Wright, M.E., & Shadomy, S.V., et al. (2014). Centers for disease control and prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis. 20 (2). https://doi.org/ 10.3201/eid2002.130687.

Hashemi, S.A., Azimian, A., & Nojumi, S., et al. (2015). A Case of Fatal Gastrointestinal Anthrax in North Eastern Iran. Case Reports in Infectious Diseases. Vol. 2015: P. 1-2. https://doi.org/ 10.1155/2015/875829.

https://doi.org/10.1155/2015/875829

Owen, J.L., Yang, T., & Mohamadzadeh, M. (2015). New Insights Into Gastrointestinal Anthrax Infection. Trends Mol Med. 21 (3): 154-163. https://doi.org/ 10.1016/j.molmed.2014.12.003.

Mwakapeje, l., Høgset, S., & Fyumagwa R., et al. (2018). Anthrax outbreaks in the humans-livestock and wildlife interface areas of Northern Tanzania: a retrospective record review 2006-2016. BMC Public Health. Jan 5. 18 (1): 106. https://doi.org/ 10.1186/s12889-017-5007-z.

Vieira, A.R., Salzer, J.S., & Traxler R.M., et al. (2017). Enhancing Surveillance and Diagnostics in Anthrax-Endemic Countries. Emerg Infect Dis.; 23(13): 147. https://doi.org/ 10.3201/eid2313.170431.

Glomski, I.J., Gimenez, A.P., & Huerre M., et al. (2007). Primary involvement of pharynx and peyer's patch in inhalational and intestinal anthrax. Plos Pathog. 3(6). https://doi.org/10.1371/journal.ppat.0030076

Liu, Y., Li, Y., & Wang Q., et al. (2020). Sporadic human cutaneous anthrax outbreak in Shaanxi Province, China: report of two cases from 2018.The Brazilian Journal of Infectious Diseases.; 24: 81-84. https://doi.org/10.1016/j.bjid.2019.12.002.

Abboud, N., De Jesus, M., & Nakouzi, A., et al. (2009). Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies. J Biol Chem. 284 (37): 25077-25086. https://doi.org/10.1074/jbc.M109.022061.

Doğanay, M., & Eşel, D. (2008). Bacillus anthracis, and other Bacillus species. Infectious Diseases and Microbiology. 3nd ed. Nobel Tıp Kitabevi. İstanbul. 2102-2114.

Walsh, M.G., Siobhan, M., & Hossain, S. (2018). The wildlife-livestock interface modulates anthrax suitability in India. BioRxiv 419465.; https://doi.org/10.1101/419465.

Abrol, S. (2016). Countering Bioterrorism Threat to India: employing global best practices and technology as force multiplier. India Q: J Int Aff. May 16: 146-162. https://doi.org/10.1177/0974928416637934.

Mourez, M. (2004). Anthrax toxins. Reviews of Physiology, Biochemistry and Pharmacology. Vol.152: 135-164.

https://doi: 10.1007/s10254-004-0028-2.

Crowe, S.R., Ash, L.L., & Engler, R.J. M., et al. (2010). Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge. The Journal of Infectious Diseases. 202 (2): 251-260. https://doi: 10.1086/653495.

Mock, M., & Fouet, A. (2001). Anthrax. Annu Rev Microbiol. Vol. 55:647-671. https://doi.org/10.1146/annurev.micro.55.1.647.

https://doi.org/10.1146/annurev.micro.55.1.647

Zwartouw, H.T., & Smith, H. (1956). Polyglutamic acid from Bacillus anthracis grown in vivo; structure and aggressin activity. Biochem J.; 63(3): 437-442. https://doi: 10.1042/bj0630437.

Stanley, J.L., & Smith, H. (1961). Purification of factor I and recognition of a third factor of the anthrax toxin. J Gen Microbiol.; Sep; 26: 49-63. https://doi: 10.1099/00221287-26-1-49.

Stanley, J.L., Sargeant, K., & Smith, H.J. (1960). Purification of factors I and II of the anthrax toxin produced in vivo. Feb; 22: 206-218. . https://doi: 10.1099/00221287-22-1-206.

Tournier, J. N., Paccani, S.R., & Quesnel-Hellmann, A. et al. (2009). Anthrax toxins: a weapon to systematically dismantle the host immune defenses. Molecular Aspects of Medicine.; 456-466. https://doi.org/10.1016/j.mam.2009.06.002.

Moayeri, M. Leppla, S.H. Vrentas, C., Pomerantsev, A.P. & Liu, S. (2015). Anthrax pathogenesis / [M. Moayeri et al.] // Annu Rev Microbiol. 69. P. 185-208. Available from: https://pubmed.ncbi.nlm.nih.gov/26195305. https://doi.org/10.1146/annurev-micro-091014-104523

Friebe S., Gisou van der Goot F., & Bürgi J. (2016). The Ins and Outs of Anthrax Toxin. Toxins.; 8 (3): 69. https://doi.org/10.3390/toxins8030069.

Kintzer, A.F., Thoren, K.L, & Sterling, H.J., et al. (2009). The protective antigen component of anthrax toxin forms functional octameric complexes. Journal of Molecular Biology. Vol. 392 (3): P. 614-629. https://doi.org/10.1016/j.jmb.2009.07.037

Lacy, D.B., Mourez, M., & Fouassier, A. (2002). Mapping the anthrax protective antigen bindings site on the lethal and edema factors. Journal of biological chemistry. 277(4): 3006-3010.

https://doi.org/10.1074/jbc.M109997200

Louise, H. (2013). CCT chaperonin complex is required for efficient delivery of anthrax toxin into the cytosol of host cells. Proc Natl Acad Sci U S A. 110 (24): 9932-9937. https://doi.org/10.1073/pnas.1302257110.

Chaudhary, A., Hilton, M.B., & Seaman, S., et al. (2012).TEM8/ANTXR1 blockade inhibits pathological angiogenesis and potentiates tumoricidal responses against multiple cancer types. Cancer Cell. Feb. 14. 21(2): 212-216. https://doi.org/10.1016/j.ccr.2012.01.004.

Felix, I., Lomada, S.K., & Barth, H., et al. (2020). Bacillus anthracis PA63 Delivers the Tumor Metastasis Suppressor Protein NDPK-A/NME1 into Breast Cancer Cellsy. Int. J. Mol. Sci. 21(9): 3295. https://doi.org/10.3390/ijms21093295.

Sahoo, K. Ch., Negi, S., & Barla, D., et al. (2020). The Landscape of Anthrax Prevention and Control: Stakeholders' Perceptive in Odisha, India. Int. J. Environ. Res. Public Health. 17(9): 3094.

https://doi.org/10.3390/ijerph17093094

Clark, A., & Wolfe, D.N. (2020). Current State of Anthrax Vaccines and Key R&D Gaps Moving Forward. Microorganisms. 8(5): 651. https://doi.org/10.3390/microorganisms8050651.

Dumas, E.K., Demiraslan, H., & Ingram, R.J., et al. (2020).Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes. PLoS ONE. 15(4): 1-17. https://doi.org/10.1371/journal.pone.0230782.

Skrypnyk, V.H. Rublenko, I.O. Harkavenko, T.O., Holovko, A.M., Zahrebelny,i V.O., & Ushkalov, V.O. ta in. (2015). Laboratorna diahnostyka sybirky tvaryn, indykatsiia zbudnyka z patolohichnoho ta biolohichnoho materialu, syrovyny tvarynnoho pokhodzhennia ta obiektiv navkolyshnoho seredovyshcha:naukovo-metodychni rekomendatsii dlia zabezpechennia praktychnoi ta samostiinoi roboty fakhivtsiv laboratorii ta naukovo-doslidnykh ustanov veterynarnoi medytsyny, vykladachiv ta studentiv fakultetiv vet. medytsyny. [Laboratory diagnosis of anthrax, indication of the pathogen from pathological and biological material, raw materials of animal origin and environmental objects: scientific and methodological recommendations to ensure practical and independent work of specialists of laboratories and research institutions of veterinary medicine, teachers and students of veterinary faculties. medicine]. Kyiv.- 78 [in Ukraine].

Zaviryukha, A.I., & Stepanyuk, O.P. (1978). Differencialnaya diagnostika vozbuditelya sibirskoj yazvy ot lozhnosibireyazvennyh bacill: dostizheniya i perspektivy borby s sibirskoj yazvoj v SSSR. [Differential diagnosis of the anthrax pathogen from false anthrax bacilli: achievements and prospects of anthrax control in the USSR]. Moscow. 130-131 [in Russian].

Downloads

Published

2020-09-09

Issue

Section

Article